Key result
Pretreatment with metabolic inhibitors decreased fibrinogen binding to PAF-acether-stimulated platelets, indicating that exposure and maintenance of binding sites depend on metabolic energy.
Answers are grounded in this paper and cite their sources.
Metabolic dependence of platelet fibrinogen binding may guide mechanistic studies; leaves open clinical translation to antithrombotic strategies.
A combination of CN- and 2-deoxy-D-glucose decreases the binding of fibrinogen to platelets stimulated with PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine). Decreased binding is found after pretreatment with metabolic inhibitors, thereby lowering the energy content before stimulation as well as at various stages after stimulation of undisturbed cells. Binding and ATP hydrolysis occur in parallel, suggesting tight coupling between both phenomena. Energy appears to be predominantly required for exposure and maintenance of accessible binding sites, whereas the interaction between fibrinogen and the exposed sites does not depend on metabolic energy.
No takes yet. Share an insight, caveat, or question.
Kloprogge et al. (1986) studied this question. Metabolic inhibitors (CN- and 2-deoxy-D-glucose) vs. Undisturbed cells was evaluated on Fibrinogen binding to platelets stimulated with PAF-acether. Pretreatment with metabolic inhibitors decreased fibrinogen binding to PAF-acether-stimulated platelets, indicating that exposure and maintenance of binding sites depend on metabolic energy.
Synapse has enriched 10 related papers. Consider them for comparative context: